CP-100356 (hydrochloride)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-108347-5MG | 5 mg | 178,00 | Add | |
| HY-108347-10MG | 10 mg | 280,00 | Add | |
| HY-108347-25MG | 25 mg | 545,00 | Add | |
| HY-108347-50MG | 50 mg | 875,00 | Add | |
| HY-108347-100MG | 100 mg | 1'407,00 | Add | |
| HY-108347-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
CP-100356 hydrochloride is an orally active dual MDR1 (P-gp)/BCRP inhibitor, with an IC50s of 0.5 and 1.5 µM for inhibiting MDR1-mediated Calcein-AM transport and BCRP-mediated Prazosin transport, respectively. CP-100356 hydrochloride is also a weak inhibitor of OATP1B1 (IC50=∼66 µM). CP-100356 hydrochloride is devoid of inhibition against MRP2 and major human P450 enzymes (IC50>15 µM)[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Metabolic Disease, Membrane Transporter/Ion Channel |
| Format | Solubility: DMSO : 11.36 mg/mL (ultrasonic;warming;heat to 60°C) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.68% |
| Molecular Formula | C31H37ClN4O6 |
| Molecular Weight | 597.1 |
| CAS-Number | 142715-48-8 |
| Storage Conditions | 4°C (Powder, sealed storage, away from moisture) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
